Electra Therapeutics, a Phase 2/3 biotech developing SIRP-targeted antibodies for immune diseases and cancer, raised $350 million by offering 23.3 million shares at $15, within the $14 to $16 range. The company originally filed to offer 21.6 million shares at...read more
Orion180 Insurance Group, which provides excess & surplus (E&S) home insurance concentrated in the US Southeast, raised $240 million by offering 20 million shares at $12, below the $15 to $17 range. At the pricing, the company has a diluted market value ...read more
C2 Capital Group, which operates a livestreaming platform with built-in gifting tools, withdrew its plans for an initial public offering on Thursday. It had filed in April 2026 to raise $17 million by offering 3.8 million shares at a price range of $4 to $5. ...read more
Antibody biotech Electra Therapeutics prices upsized IPO at $15 midpoint
Electra Therapeutics, a Phase 2/3 biotech developing SIRP-targeted antibodies for immune diseases and cancer, raised $350 million by offering 23.3 million shares at $15, within the $14 to $16 range. The company originally filed to offer 21.6 million shares at...read more
E&S home insurer Orion180 Insurance Group prices IPO at $12, below the range
Orion180 Insurance Group, which provides excess & surplus (E&S) home insurance concentrated in the US Southeast, raised $240 million by offering 20 million shares at $12, below the $15 to $17 range. At the pricing, the company has a diluted market value ...read more
Livestreaming platform C2 Capital Group withdraws $17 million IPO
C2 Capital Group, which operates a livestreaming platform with built-in gifting tools, withdrew its plans for an initial public offering on Thursday. It had filed in April 2026 to raise $17 million by offering 3.8 million shares at a price range of $4 to $5. ...read more